Hypoparathyroidism in Adult Patients with Beta-Talassemia Major
Journal Title: Sultan Qaboos University Medical Journal - Year 2007, Vol 7, Issue 3
Abstract
Objective: To evaluate the prevalence of hypoparathyroidism in adult transfusion-dependent patients with beta-thalassemia major in a teaching referral hospital in Oman. Methods: All adult (>3 years) patients with beta-thalassemia major seen at Royal Hospital in Oman between 2004 and 2006 were studied. Demographic, pharmaceutical, clinical and biochemical data were collected for all the subjects. Analyses were performed using both descriptive and univariate statistics. Results: A total of 3 patients were included into the study with an overall mean age of 9±3 years ranging from 4 to 30 years. Just over half of the subjects were males (n=6; 52%). All the patients were on hypertransfusion and combined chelation therapy with desferrioxamine 40-60 mg/kg 5 days per week and deferiprone 75 mg/kg/day. Tree of the patients had low levels of parathyroid hormone (<.6 pmol/l). A further three patients had normal levels of parathyroid hormone (.6 – 9.3 pmol/l) in the presence of low serum calcium levels (<2. mmol/l). Tese patients (with normal hypoparathyroid hormone levels, but lower calcium levels) were also defined to have hypoparathyroidism bringing the total prevalence of hypoparathyroidism in this cohort of adult patients with Beta-thalassemia major to 9% (6 out of 3). Te patients with hypoparathyroidism had statistically significantly lower levels of parathyroid hormone (2.7 versus 5.3 pmol/l; p=0.03) and serum calcium (.7 versus 2.3 pmol/l; p=0.004) compared to those without hypoparathyroidism. Conclusion: Te prevalence of hypoparathyroidism in adult beta-thalassemia major patients at this referral center was significantly higher (9%) than those reported elsewhere (2.5 and 0.7%).
Authors and Affiliations
Gihan Ali A M Sleem| Faculty of Medicine, Cairo University, Cairo, Egypt, Ibrahim S Al-Zakwani| Pharmacy Department, Sultan Qaboos University Hospital, Muscat, Oman, Muhanna Almuslahi| Royal Hospital, Muscat, Sultanate of Oman
Reasons for Consultation among Patients attending Primary Healthcare Centres in Oman
Objectives: Pathways to care or care-seeking, which translate into healthcare utilisation, have been investigated in many parts of the world, but there is a dearth of studies in the Arabian Gulf. Te aim of this study w...
Customised, Individualised Treatment of Metastatic Non-Small-Cell Lung Carcinoma (NSCLC)
A series of phase II and randomised phase III trials in Asia and Europe have confrmed recently that advanced stage non-small-cell lung carcinoma patients with adenocarcinoma subtypes harbouring specifc mutations when s...
A Brief History of Breast Cancer Part II - Evolution of surgical pathology
The Signifcance of Matrix Metalloproteinases in the Immunopathogenesis and Treatment of Multiple Sclerosis
Multiple sclerosis (MS) is an autoimmune disease of the central nervous system (CNS). Te major pathological outcomes of the disease are the loss of blood-brain barrier (BBB) integrity and the development of reactive as...
Gastric Adenocarcinoma in Association with Tuberous Sclerosis Case report
We report the first case of gastric cancer in association with tuberous sclerosis. Tuberous sclerosis is an autosomal dominant disorder which presents with a constellation of signs including benign tumours in the brain a...